Aimei Health Files 8-K on Financial Obligations
Ticker: AFJKR · Form: 8-K · Filed: Sep 5, 2025 · CIK: 1979005
Sentiment: neutral
Topics: financial-obligation, 8-k, filing
Related Tickers: AMH
TL;DR
Aimei Health (AMH) filed an 8-K on 9/5/25 about new financial obligations.
AI Summary
Aimei Health Technology Co., Ltd. filed an 8-K on September 5, 2025, reporting the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates a change in Aimei Health's financial commitments, which could impact its financial health and future operations.
Risk Assessment
Risk Level: medium — The creation of new financial obligations, without further details, introduces uncertainty about the company's financial stability.
Key Players & Entities
- Aimei Health Technology Co., Ltd. (company) — Registrant
- September 5, 2025 (date) — Date of Report
- 001-41880 (other) — Commission File Number
FAQ
What specific financial obligation is Aimei Health reporting?
The filing states the creation of a 'Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement' but does not specify the exact nature or amount of the obligation in the provided text.
When was this 8-K filing submitted?
The filing was submitted on September 5, 2025.
What is Aimei Health Technology's jurisdiction of incorporation?
Aimei Health Technology Co., Ltd. is incorporated in the Cayman Islands.
What is the company's SIC code?
The Standard Industrial Classification (SIC) code provided is BLANK CHECKS [6770].
What other items are included in this 8-K filing besides the financial obligation?
The filing also includes 'Financial Statements and Exhibits'.
Filing Stats: 789 words · 3 min read · ~3 pages · Grade level 13.9 · Accepted 2025-09-05 16:05:21
Key Financial Figures
- $0.0001 — registered Ordinary Shares, par value $0.0001 per share AFJK The Nasdaq Stock Mar
- $150,000 — the Termination Date An aggregate of $150,000 (the " Extension Payment ") has been de
- $75,000 — ween the Payees, with each contributing $75,000, to fund the Extension Payment. The Pro
- $10.00 — ate units of the Company, at a price of $10.00 per unit, each consisting of one ordina
Filing Documents
- form8-k.htm (8-K) — 48KB
- ex10-1.htm (EX-10.1) — 43KB
- 0001493152-25-012726.txt ( ) — 315KB
- afjk-20250905.xsd (EX-101.SCH) — 4KB
- afjk-20250905_def.xml (EX-101.DEF) — 26KB
- afjk-20250905_lab.xml (EX-101.LAB) — 37KB
- afjk-20250905_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 7KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 5, 2025 Aimei Health Technology Co., Ltd By: /s/ Junheng Xie Name: Junheng Xie Title: Chief Executive Officer and Director (Principal Executive Officer)